Putting the brakes on aging
Aging is a leading risk factor for a number of debilitating conditions, including heart disease, cancer and Alzheimer’s disease, to name a few. This makes the need for anti-aging therapies all the more urgent. Now, Salk Institute researchers have developed a new gene therapy to help decelerate the aging process.
The findings, published on February 18, 2018 in the journal Nature Medicine, highlight a novel CRISPR/Cas9 genome-editing therapy that can suppress the accelerated aging observed in mice with Hutchinson-Gilford progeria syndrome, a rare genetic disorder that also afflicts humans. This treatment provides important insight into the molecular pathways involved in accelerated aging, as well as how to reduce toxic proteins via gene therapy.
“Aging is a complex process in which cells start to lose their functionality, so it is critical for us to find effective ways to study the molecular drivers of aging,” says Juan Carlos Izpisua Belmonte, a professor in Salk’s Gene Expression Laboratory and senior author of the paper. “Progeria is an ideal aging model because it allows us to devise an intervention, refine it and test it again quickly.”
With an early onset and fast progression, progeria is one of the most severe forms of a group of degenerative disorders caused by a mutation in the LMNA gene. Both mice and humans with progeria show many signs of aging, including DNA damage, cardiac dysfunction and dramatically shortened life span. The LMNA gene normally produces two similar proteins inside a cell: lamin A and lamin C. Progeria shifts the production of lamin A to progerin. Progerin is a shortened, toxic form of lamin A that accumulates with age and is exacerbated in those with progeria.
“Our goal was to diminish the toxicity from the mutation of the LMNA gene that leads to accumulation of progerin inside the cell,” says co-first author Hsin-Kai Liao, a staff researcher in the Izpisua Belmonte lab. “We reasoned that progeria could be treated by CRISPR/Cas9-targeted disruption of both lamin A and progerin.”
The researchers utilized the CRISPR/Cas9 system to deliver the gene therapy into the cells of the progeria mouse model expressing Cas9. An adeno-associated virus (AAV) was injected containing two synthetic guide RNAs and a reporter gene. The guide RNA ushers the Cas9 protein to a specific location on the DNA where it can make a cut to render lamin A and progerin nonfunctional, without disrupting lamin C. The reporter helps researchers track the tissues that were infected with the AAV.
Two months after the delivery of the therapy, the mice were stronger and more active, with improved cardiovascular health. They showed decreased degeneration of a major arterial blood vessel and delayed onset of bradycardia (an abnormally slow heart rate)—two issues commonly observed in progeria and old age. Overall, the treated progeria mice had activity levels similar to normal mice, and their life span increased by roughly 25 percent.
“Once we improve the efficiency of our viruses to infect a wide range of tissues, we are confident that we will be able to increase life span further,” says Pradeep Reddy, a postdoctoral fellow in the Izpisua Belmonte lab and an author of the paper.
Taken together, the results suggest that targeting lamin A and progerin using a CRISPR/Cas9 system can dramatically improve the physiological health and life span of progeria mice. These results provide a significant new understanding of how scientists may eventually be able to target molecular drivers of aging in humans.
Future efforts will focus on making the therapy more effective and will refine it for human use. Currently, there is no cure for progeria, so the symptoms are managed and complications are treated as they arise.
“This is the first time a gene editing therapy has been applied to treat progeria syndrome,” says Izpisua Belmonte, holder of the Roger Guillemin Chair. “It will need some refinements, but it has far fewer negative effects compared to other options available. This is an exciting advancement for the treatment of progeria.”
Learn more: Putting the brakes on aging
The Latest on: Anti-aging therapies
via Google News
The Latest on: Anti-aging therapies
- "Miracle Molecule" Expected to Usher in a New Era in Anti-Aging Skincareon January 23, 2020 at 12:07 am
In humans, intravenous treatment with NAD+ has been used by holistic medical specialists to reverse ... “It’s given hope to me; it’s given hope to them.” The name NADIA means hope. The anti-aging ...
- LDUNA Aesthetics and Wellness Center Grand Opening Celebration, Jan. 22on January 22, 2020 at 2:28 pm
The anti-aging services offered are genetic testing and bio-identical hormone replacement therapy, to ensure peak biological performance, while Lduna’s regenerative medicine category includes the ...
- Global Anti-Aging Therapies and Services Marketon January 22, 2020 at 2:39 am
The Global Anti-Aging Therapies and Services Market study with 100+ market data Tables, Pie Chat, Graphs & Figures is now released by Data Bridge Market Research. The report presents a complete ...
- Dr. Nathan S. Bryan Partners with LightStim at The Medical Spa Showon January 21, 2020 at 6:46 am
As demonstrated in numerous studies, low-level light therapy (LLLT ... those products is Pneuma Nitric Oxide Serum - the first antiaging skin care serum that restores Nitric Oxide production ...
- We know exercise is good for your skin. This protein mimics those effects in mice.on January 20, 2020 at 6:21 am
Justin Crane, an assistant professor of biology at Northeastern, and Wesley Wong, a fourth-year doctoral student in Crane’s lab, are studying these processes in aging mice to boost new anti-aging ...
- Mark Murphy column: Quackery, charlatanism and medical pseudoscience in the 21st centuryon January 18, 2020 at 2:42 pm
Netflix says that “The Goop ab with Gwyneth Paltrow is a six-episode series, guiding the deeply inquisitive viewer in an exploration of boundary-pushing wellness topics, including: psychedelics, cold ...
- Las Vegas' Healor Primary Care Practice Offers Affordable Careon January 18, 2020 at 6:00 am
LAS VEGAS, Jan. 18, 2020 /PRNewswire-PRWeb/ -- Healor Primary Care announces the arrival of affordable medical care with economic wellness plans and a wholesale drug pharmacy.
- Hormone replacement is helping patients stay healthy later in life.on January 17, 2020 at 8:53 pm
And that's helping some middle-aged people feel like they are in their thirties. They changed their health and dropped weight because of hormone replacement therapy. They say taking the step was ...
- The Ultimate Miami Spa Guide: 15 Luxurious Places to Treat Yourselfon January 17, 2020 at 12:13 pm
Valmont uses the best of Switzerland’s natural resources and glacial spring water combined with their patented triple DNA for the ultimate in anti-aging products. The intimate spa features four ...
- Anti-Aging Products and Therapies Market Size to surge at 10.8% CAGR Poised to Touch USD 16930 Million by 2025on January 17, 2020 at 3:17 am
Global Anti-Aging Products and Therapies Market report provides a basic overview of the Anti-Aging Products and Therapies including definitions, classifications, applications and Anti-Aging Products ...
via Bing News